Clinical Endpoints Could Help Chronic Condition Drugs Switch
This article was originally published in The Tan Sheet
Executive Summary
Companies attempting to switch a drug OTC for a chronic condition might have a stronger case if supported by data focusing on clinical endpoints rather than just markers, a workshop group surmised at the Consumer Healthcare Products Association Research & Scientific Development Conference in Washington, D.C. Oct. 28-29.